YU46087B - Postupak za dobijanje analoga rebekamicina - Google Patents

Postupak za dobijanje analoga rebekamicina

Info

Publication number
YU46087B
YU46087B YU208687A YU208687A YU46087B YU 46087 B YU46087 B YU 46087B YU 208687 A YU208687 A YU 208687A YU 208687 A YU208687 A YU 208687A YU 46087 B YU46087 B YU 46087B
Authority
YU
Yugoslavia
Prior art keywords
group
alkyl
rebecamycin
alkoxycarbonyl
mono
Prior art date
Application number
YU208687A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU208687A (en
Inventor
T. Kaneko
H.S. Wong
J.J. Utzig
Original Assignee
Bristol-Myers Company New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Company New York filed Critical Bristol-Myers Company New York
Publication of YU208687A publication Critical patent/YU208687A/xx
Publication of YU46087B publication Critical patent/YU46087B/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044Pyrrole radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
YU208687A 1986-11-21 1987-11-18 Postupak za dobijanje analoga rebekamicina YU46087B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/933,428 US4785085A (en) 1986-11-21 1986-11-21 Rebeccamycin analogs

Publications (2)

Publication Number Publication Date
YU208687A YU208687A (en) 1988-10-31
YU46087B true YU46087B (sh) 1992-12-21

Family

ID=25463937

Family Applications (1)

Application Number Title Priority Date Filing Date
YU208687A YU46087B (sh) 1986-11-21 1987-11-18 Postupak za dobijanje analoga rebekamicina

Country Status (28)

Country Link
US (1) US4785085A (2)
EP (1) EP0269025B1 (2)
JP (1) JPS63198695A (2)
KR (1) KR910000897B1 (2)
CN (1) CN1019806B (2)
AT (1) ATE84539T1 (2)
AU (1) AU614068B2 (2)
CA (1) CA1287349C (2)
CS (1) CS265248B2 (2)
CY (1) CY1701A (2)
DE (1) DE3783577T2 (2)
DK (1) DK165986C (2)
EG (1) EG18409A (2)
ES (1) ES2053510T3 (2)
FI (1) FI86189C (2)
GR (1) GR3006776T3 (2)
HK (1) HK49093A (2)
HU (1) HU201773B (2)
IE (1) IE60595B1 (2)
IL (1) IL84515A (2)
MX (1) MX9202849A (2)
MY (1) MY102722A (2)
NO (1) NO167741C (2)
NZ (1) NZ222544A (2)
PT (1) PT86188B (2)
SG (1) SG25193G (2)
YU (1) YU46087B (2)
ZA (1) ZA878714B (2)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 K−252誘導体
DE3835842A1 (de) * 1988-10-21 1990-04-26 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
US5438050A (en) * 1988-02-06 1995-08-01 Godecke Aktiengesellschaft Indolocarbazole derivatives, processes for their preparation and compositions containing them
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
US5496809A (en) * 1989-05-10 1996-03-05 Bristol-Myers Squibb Co Stable solutions of rebeccamycin analog
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
CA2037596C (en) * 1990-03-06 1995-07-18 Kin Sing Lam Rebeccamycin analog by bromide precursor feeding
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Rebeccamycin analogs, their production and pharmaceutical compositions containing them
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
JP3064416B2 (ja) * 1990-05-11 2000-07-12 萬有製薬株式会社 抗腫瘍性物質be―13793c誘導体
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5437996A (en) * 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5591842A (en) * 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
US5547976A (en) * 1992-03-20 1996-08-20 Burroughs Wellcome Co. Further indole derivatives with antiviral activity
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
DK0657411T3 (da) * 1993-12-07 1999-11-15 Lilly Co Eli Forbedret syntese af bisindolylmaleimider
NO308798B1 (no) * 1993-12-07 2000-10-30 Lilly Co Eli Proteinkinase-C-hemmere, anvendelse av samme for fremstilling av farmasøytika samt farmasøytisk formulering omfattende samme
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
ES2236702T3 (es) * 1993-12-23 2005-07-16 Eli Lilly And Company Inhibidores de la proteina quinasa c.
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5804564A (en) * 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
WO1995030682A1 (en) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
EP0769555B1 (en) * 1994-06-13 2003-09-03 Banyu Pharmaceutical Co., Ltd. Gene coding for glycosyltransferase and use thereof
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
DK0695755T3 (da) * 1994-08-04 1999-06-28 Hoffmann La Roche Pyrrolocarbazoler
WO1997009339A1 (fr) * 1995-09-05 1997-03-13 Banyu Pharmaceutical Co., Ltd. Derives antitumoraux d'indolopyrrolocarbazole
EP0888339A4 (en) * 1996-03-20 2001-02-28 Lilly Co Eli SYNTHESIS OF INDOLYLMALEINIMIDES
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6653290B2 (en) * 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
KR20030085035A (ko) 2001-03-22 2003-11-01 브리스톨-마이어스스퀴브컴파니 토포아이소머라아제 i 선택성 세포독성인돌로피롤로카바졸 당 유도체
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
EP1666485A1 (en) * 2003-09-16 2006-06-07 Banyu Pharmaceutical Co., Ltd. Novel indolopyrrolocarbazole derivative with antitumor activity
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102125578B (zh) * 2010-11-24 2013-03-27 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法
CN102898489B (zh) * 2010-11-24 2014-04-02 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) * 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4552842A (en) * 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ucn―01

Also Published As

Publication number Publication date
DK612987A (da) 1988-05-22
JPS63198695A (ja) 1988-08-17
AU614068B2 (en) 1991-08-22
SG25193G (en) 1993-05-21
FI875091A0 (fi) 1987-11-18
ATE84539T1 (de) 1993-01-15
CS265248B2 (en) 1989-10-13
NO874857L (no) 1988-05-24
EP0269025A3 (en) 1990-08-29
HU201773B (en) 1990-12-28
ZA878714B (2) 1988-05-20
FI86189B (fi) 1992-04-15
MY102722A (en) 1992-09-30
NZ222544A (en) 1990-11-27
DK165986B (da) 1993-02-22
KR880006246A (ko) 1988-07-22
FI86189C (fi) 1992-07-27
EG18409A (en) 1993-02-28
HK49093A (en) 1993-05-27
NO167741C (no) 1991-12-04
ES2053510T3 (es) 1994-08-01
CN87107928A (zh) 1988-08-10
CA1287349C (en) 1991-08-06
EP0269025B1 (en) 1993-01-13
DK165986C (da) 1993-07-19
NO874857D0 (no) 1987-11-20
DK612987D0 (da) 1987-11-20
AU8114887A (en) 1988-05-26
DE3783577T2 (de) 1993-05-19
CS824987A2 (en) 1989-01-12
IE873152L (en) 1988-05-21
IE60595B1 (en) 1994-07-27
US4785085A (en) 1988-11-15
KR910000897B1 (ko) 1991-02-12
DE3783577D1 (de) 1993-02-25
FI875091A7 (fi) 1988-05-22
NO167741B (no) 1991-08-26
GR3006776T3 (2) 1993-06-30
IL84515A0 (en) 1988-04-29
IL84515A (en) 1991-11-21
PT86188A (en) 1987-12-01
YU208687A (en) 1988-10-31
EP0269025A2 (en) 1988-06-01
CN1019806B (zh) 1992-12-30
MX9202849A (es) 1992-06-30
CY1701A (en) 1994-01-14
PT86188B (pt) 1990-11-07
HUT45543A (en) 1988-07-28
JPH05400B2 (2) 1993-01-05

Similar Documents

Publication Publication Date Title
YU46087B (sh) Postupak za dobijanje analoga rebekamicina
AU598491B2 (en) Pyridyl-methylthio substituted benzimidazoles
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
ATE14423T1 (de) Hydroxamsaeurederivate vom typ der mannich-basen mit verbesserter biologischer verfuegbarkeit von nicht-steroiden entzuendungshemmern, verfahren zur herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzung.
DK44682A (da) Fremgangsmaade til fremstilling af substituerede imidazolderivater
ES8307760A1 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
ES8700856A1 (es) Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina
DK531282A (da) Fremgangsmaade til fremstilling af substituerede imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf
ATE41423T1 (de) 1,6-naphthyridinon-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
GB1053825A (2)
ATE18196T1 (de) 1,4-acyloxynaphthalenderivate, diese enthaltende kompositionen, verfahren fuer ihre herstellung und zwischenprodukte dafuer.
ATE5141T1 (de) Xanthon- und thioxanthonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR910011760A (ko) 글리세롤 유도체, 이의 제조 방법 및 이를 함유하는 치료 조성물
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
DE2965377D1 (en) 6-amino substituted n-pyrrolyl-3-pyridazine amines, their preparation, and pharmaceutically antihypertensive compositions containing them
KR830005164A (ko) 이종원자고리화합물의 제조방법 및 이의 조성물
ES8105704A1 (es) Procedimiento de preparacion de nuevos eteres oximas, de sussales de adicion acidas y de sus derivados amonicos cuater- narios
KR880007539A (ko) 축합된 디아제피논, 이의 제조방법 및 이들 화합물을 함유하는 약제학적 조성물
HK67287A (en) Ergoline derivatives
EP0026989A3 (en) Nitrosourea derivatives, process for preparing them, pharmaceutical compositions containing them and intermediates for their preparation
GB1469197A (en) Preparation of 1-aminoalkyl triazolobenzodiazepines
DE69113851D1 (de) Verfahren zur Herstellung von optisch aktiven Norbornylaminderivaten.
DK527483D0 (da) Fremgangsmade til fremstilling af benzazepinderivater
ATE36154T1 (de) 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE25968T1 (de) 1,1-diphenylpropanol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.